Yohei Doi

35.8k total citations · 10 hit papers
373 papers, 22.3k citations indexed

About

Yohei Doi is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, Yohei Doi has authored 373 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 265 papers in Molecular Medicine, 111 papers in Endocrinology and 103 papers in Epidemiology. Recurrent topics in Yohei Doi's work include Antibiotic Resistance in Bacteria (265 papers), Antibiotics Pharmacokinetics and Efficacy (98 papers) and Vibrio bacteria research studies (55 papers). Yohei Doi is often cited by papers focused on Antibiotic Resistance in Bacteria (265 papers), Antibiotics Pharmacokinetics and Efficacy (98 papers) and Vibrio bacteria research studies (55 papers). Yohei Doi collaborates with scholars based in United States, Japan and China. Yohei Doi's co-authors include David L. Paterson, David van Duin, Guo‐Bao Tian, Yoshichika Arakawa, Ryan K. Shields, Robert A. Bonomo, Jennifer Adams‐Haduch, Jian–Hua Liu, Xi Huang and Jianzhong Shen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Yohei Doi

355 papers receiving 21.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

2015 3.9k citations Yang Wang, Yohei Doi et al. profile →
The global epidemiology of carbapenemase-producing Enterobacteriaceae

2016 694 citations David van Duin, Yohei Doi profile →
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

2020 540 citations Roger Echols, Yuko Matsunaga et al. profile →
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)

2020 504 citations Yohei Doi, Guo‐Bao Tian et al. Emerging Microbes & Infections profile →
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

2017 479 citations David van Duin, Yohei Doi et al. Clinical Infectious Diseases profile →
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

2019 443 citations Yohei Doi Clinical Infectious Diseases profile →
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

2012 438 citations David L. Paterson, Brian A. Potoski et al. Antimicrobial Agents and Chemotherapy profile →
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla _KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

2016 393 citations Ryan K. Shields, Liang Chen et al. Antimicrobial Agents and Chemotherapy profile →
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

2017 369 citations Ryan K. Shields, M. Hong Nguyen et al. Antimicrobial Agents and Chemotherapy profile →
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19

2024 46 citations Hiroshi Yotsuyanagi, Norio Ohmagari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yohei Doi United States	70	17.5k	6.1k	6.0k	4.5k	4.4k	373	22.3k
Christian G. Giske Sweden	51	15.7k 0.9×	4.3k 0.7×	5.8k 1.0×	5.6k 1.3×	3.6k 0.8×	233	23.1k
Gian María Rossolini Italy	78	16.6k 1.0×	4.3k 0.7×	6.6k 1.1×	4.3k 1.0×	3.9k 0.9×	568	23.6k
Neil Woodford United Kingdom	84	17.4k 1.0×	4.8k 0.8×	8.1k 1.3×	4.1k 0.9×	4.2k 0.9×	350	24.1k
Thierry Naas France	69	16.0k 0.9×	4.1k 0.7×	7.7k 1.3×	2.9k 0.6×	3.5k 0.8×	354	20.8k
Karen Bush United States	72	17.4k 1.0×	7.3k 1.2×	5.5k 0.9×	4.3k 1.0×	4.3k 1.0×	218	22.7k
Johann Pitout Canada	67	14.4k 0.8×	2.6k 0.4×	7.8k 1.3×	4.2k 0.9×	3.2k 0.7×	201	17.1k
Rafael Cantón Spain	81	15.7k 0.9×	4.6k 0.8×	6.7k 1.1×	8.4k 1.9×	4.8k 1.1×	759	30.4k
David M. Livermore United Kingdom	96	23.7k 1.4×	8.7k 1.4×	8.3k 1.4×	6.5k 1.5×	5.4k 1.2×	405	31.9k
David C. Hooper United States	78	12.8k 0.7×	7.0k 1.1×	3.5k 0.6×	4.8k 1.1×	3.0k 0.7×	274	24.2k
George A. Jacoby United States	62	18.7k 1.1×	5.9k 1.0×	6.7k 1.1×	3.9k 0.9×	5.7k 1.3×	152	23.1k

Countries citing papers authored by Yohei Doi

Since Specialization

Citations

This map shows the geographic impact of Yohei Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Doi more than expected).

Fields of papers citing papers by Yohei Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Doi. The network helps show where Yohei Doi may publish in the future.

Co-authorship network of co-authors of Yohei Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Doi. A scholar is included among the top collaborators of Yohei Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Doi. Yohei Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suzuki, Masahiro, et al.. (2025). In vitro activity of aztreonam in combination with relebactam against gram-negative pathogens producing various serine and metallo-β-lactamases. Journal of Global Antimicrobial Resistance. 42. 73–79. 1 indexed citations

Uehara, Takeki, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.. (2025). Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial. Antiviral Research. 236. 106097–106097. 1 indexed citations

Uehara, Yuki, et al.. (2025). Restoring the 2-set blood culture practice after the resolution of supply shortage. Infection Control and Hospital Epidemiology. 46(6). 659–661.

Jiang, Jianping, Leilei Wang, Yiyi Hu, et al.. (2025). Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFIIK34 KPC-2 plasmid. EBioMedicine. 113. 105627–105627. 12 indexed citations

Galdino, Anna Clara Milesi, et al.. (2024). Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro. Nature Microbiology. 9(3). 631–646. 20 indexed citations

Yotsuyanagi, Hiroshi, Norio Ohmagari, Yohei Doi, et al.. (2023). A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part). Medicine. 102(8). e33024–e33024. 29 indexed citations

Feng, Siyuan, Jiachen Li, Yong Chen, et al.. (2022). MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteria. Emerging Microbes & Infections. 11(1). 1236–1249. 25 indexed citations

Nordmann, Patrice, Ryan K. Shields, Yohei Doi, et al.. (2022). Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials. Microbial Drug Resistance. 28(4). 398–407. 53 indexed citations

Mukae, Hiroshi, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.. (2022). Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study. Clinical Infectious Diseases. 76(8). 1403–1411. 90 indexed citations

10.

Lv, Luchao, Miao Wan, Cheng-Zhen Wang, et al.. (2020). Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae. mBio. 11(2). 202 indexed citations

11.

Babiker, Ahmed, Daniel R. Evans, M. Patrick Griffith, et al.. (2020). Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades. Journal of Clinical Microbiology. 58(9). 23 indexed citations

12.

Harada, Sohei & Yohei Doi. (2018). Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration. Journal of Clinical Microbiology. 56(9). 68 indexed citations

13.

Tiba‐Casas, Monique Ribeiro, et al.. (2018). Emergence of CMY-2-Producing Salmonella Heidelberg Associated with IncI1 Plasmids Isolated from Poultry in Brazil. Microbial Drug Resistance. 25(2). 271–276. 18 indexed citations

14.

Luo, Juan, et al.. (2017). Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli Isolates from Retail Vegetables in China. Antimicrobial Agents and Chemotherapy. 61(10). 59 indexed citations

15.

Fernandes, Sueli Aparecida, Carlos Henrique Camargo, Gabriela Rodrigues Francisco, et al.. (2016). Prevalence of Extended-Spectrum β-Lactamases CTX-M-8 and CTX-M-2-Producing Salmonella Serotypes from Clinical and Nonhuman Isolates in Brazil. Microbial Drug Resistance. 23(5). 580–589. 16 indexed citations

16.

Guo, Qinglan, et al.. (2016). Comparative analysis of an IncR plasmid carryingarmA,bla_DHA-1andqnrB4fromKlebsiella pneumoniaeST37 isolates. Journal of Antimicrobial Chemotherapy. 71(4). 882–886. 33 indexed citations

17.

Shields, Ryan K., Liang Chen, Shaoji Cheng, et al.. (2016). Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla _KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Antimicrobial Agents and Chemotherapy. 61(3). 393 indexed citations breakdown →

18.

Takahashi, Naoki, et al.. (2013). Pharmacokinetics of atovaquone suspension and atovaquone/proguanil combination tablet in healthy Japanese subjects. 61(4). 335–342. 1 indexed citations

19.

Fernandes, Sueli Aparecida, et al.. (2009). CTX-M-2–Producing Salmonella Typhimurium Isolated from Pediatric Patients and Poultry in Brazil. Microbial Drug Resistance. 15(4). 317–321. 28 indexed citations

20.

Doi, Yohei, Brian A. Potoski, Jennifer Adams‐Haduch, et al.. (2008). Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound. Journal of Clinical Microbiology. 46(12). 4083–4086. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact